EarlySense Inc president Tim O’Malley accepted an award on behalf of the company at the AAMI 2016 Conference Awards Ceremony, which recognizes leaders and innovators whose efforts have moved the healthcare technology industry forward to improve patient care and safety, according to a press announcement by EarlySense
The AAMI 2016 Conference Awards honored an impressive lineup of healthcare technology experts, patient safety champions, young professionals, and industry partners for their leadership, commitment, and contributions to the field.
EarlySense works closely with the AAMI Foundation to expand the messages and tools developed by the foundation’s National Coalition to Promote Continuous Monitoring of Patients on Opioids, the company said. The EarlySense System continuously monitors patient heart rate, respiratory rate and motion via an under-the-mattress sensor. It is designed to assist clinicians in identifying patient risk early, helping clinicians to reduce the chance of respiratory depression and decreasing the risk of complications, including patient death.
“Use of opioid-based medications presents a risk which may significantly elevate the occurrence of adverse events due to respiratory depression, therefore continuous monitoring of these patients is critical,” said O’Malley. “We are pleased to work alongside AAMI to raise awareness of this challenge, while continuing to expand the reach of our technology to improve healthcare safety across the country.”
Marilyn Neder Flack, executive director of the AAMI Foundation stated, “I am very grateful that EarlySense is a premiere partner with the AAMI Foundation in the National Coalition to Promote Continuous Monitoring of Patients on Opioids. This level of support and involvement in this critically important initiative demonstrates EarlySense’s commitment to ensuring no patient on opioids will have a poor outcome due to undetected opioid induced respiratory depression.”
More information is available at EarlySense’s website.
